UNSPSC 51461601: Calcium/iodine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HA000. This VA Drug Class (HA000) classifies this compound as belonging to the group HERBS/ALTERNATIVE THERAPIES.

UNSPSC 51461601 Calcium/iodine, a Commodity code, encompasses nutritional supplements and pharmaceutical ingredients sourced through state and local cooperative purchasing agreements, with recent activity centered on multi-state generic pharmaceutical and over-the-counter product procurement. State and local governments buy calcium and iodine-containing products as part of broader pharmaceutical supply contracts distributed through authorized wholesalers to public health facilities, correctional institutions, and other state-administered entities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body soliciting under this code in recent months, with its procurement model aggregating demand across participating state and local government facilities to achieve volume-based pricing advantages. Individual states and counties may also solicit calcium and iodine products independently through smaller RFQs and ITBs, but cooperative purchasing vehicles like MMCAP dominate the visible procurement landscape for pharmaceutical commodities at this tier.

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026) exemplifies the current activity under this code and extends to Oregon and other participating states beyond Minnesota. The solicitation requires vendors to supply products with specific National Drug Codes through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson—with contract effectiveness set for July 1, 2026. Evaluation weighting favors price competitiveness at 75 percent, with secondary criteria including fixed pricing structure (10 percent), EDI capability (5 percent), administrative fee compliance (5 percent), and data format requirements (5 percent). Vendors must certify cGMP compliance and Drug Supply Chain Security Act adherence, maintain relationships with at least two authorized wholesalers, and carry $5 million commercial general liability insurance. No set-aside designations are identified in available documentation.